Quidel QuidelOrtho Preliminary Q4 Earnings Beat Estimates The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent. QuidelOrtho Continues to See Supply Chain Impacts; Combined Q3 Revenues up 54 Percent Premium The firm also said it will shift its near-term regulatory and commercial strategy for its Savanna molecular diagnostic instrument. GenomeWeb Top 40 up 3 Percent in October After Two Months of Losses The Dow Jones Industrial Average was up 14 percent, while the Nasdaq was up 4 percent, and the Nasdaq Biotech Index was up 9 percent. QuidelOrtho Reports Preliminary Q3 Revenues The firm forecast preliminary revenues in the range of $782 million to $785 million for the first full quarter since the merger of Quidel and Ortho Clinical Diagnostics. QuidelOrtho Board Authorizes $300M Share Repurchase The firm said it will repurchase up to $300 million in shares of common stock while also prioritizing R&D and manufacturing expansion. Aug 5, 2022 QuidelOrtho Q2 Revenues Rise 34 Percent Jul 20, 2022 UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies May 27, 2022 In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More May 4, 2022 Quidel Q1 Revenues More Than Double on COVID-19 Immunoassay Sales Apr 8, 2022 Quidel Expects up to $1B in Q1 Revenues Feb 17, 2022 Quidel Q4 Revenues Drop 21 Percent, Beat Estimates Jan 13, 2022 JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More Jan 6, 2022 Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates Dec 1, 2021 GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Nov 4, 2021 Quidel Q3 Revenues Up 7 Percent, Beat Analysts' Estimate Oct 8, 2021 Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate Oct 1, 2021 GenomeWeb Index Takes 7 Percent Tumble in September Aug 5, 2021 Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates Jul 26, 2021 Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business Jul 19, 2021 OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer Jul 12, 2021 Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel Jul 7, 2021 Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results Jun 1, 2021 GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April Apr 23, 2021 Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations Mar 10, 2021 Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.